IRMD (Iradimed) Prakiraan pendapatan perusahaan
IRADIMED CORPORATION (IRMD) maintains its leadership in the MRI-compatible equipment segment, ensuring high operating profitability. However, government budget cuts and technological shifts create certain risks. Supply stability is guaranteed by local assembly and strategic component reserves. The company's expected trading volumes reflect the current market valuation of its prospects, with this indicator equal to 0.12.
Rincian analitis lan laporan data perusahaan IRADIMED Corp (IRMD)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal IRADIMED CORPORATION|IRMD - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Iradimed|IRMD - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku IRADIMED Corp|IRMD - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan IRADIMED|Indikator likuiditas cepet iradimed.com
- statistik bathi lan rasio pasar:
IRMD - Bathi pungkasan|Proyeksi bathi mangsa ngarep IRADIMED CORPORATION|IRMD - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep IRADIMED|IRMD - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan IRADIMED Corp|IRMD - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) IRADIMED|IRMD - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan iradimed.com|IRMD - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep IRADIMED CORPORATION
- data dodolan lan asil:
Analisis fundamental perusahaan:IRADIMED CORPORATION
Investors are attracted to the operating model of IRADIMED CORPORATION (IRMD), where the market consensus on future earnings offsets the lag in quarterly reporting, creating a continuous revenue forecast series. The trend in target sales volumes confirms the resilience of its niche leadership in the MRI equipment segment, allowing for an assessment of the business's fundamental strength through expected sales intensity and the stability of the service stream.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan BSX (Boston Scientific)|EW (edwards.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan ResMed RMD|PODD - Volume dodolan mangsa ngarep perusahaan|Zimmer - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan CooperSurgical|ALGN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GMED|TMDX (TransMedics Group, Inc.) - Prakiraan volume dodolan|Alphatec Holdings (ATEC) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan AORT|Volume dodolan mangsa ngarep perusahaan Enovis Inc. ENOV|Prakiraan volume dodolan IART (Integra LifeSciences)|Prakiraan volume dodolan establishmentlabs.com ESTA|BBNX - Prakiraan pendapatan perusahaan|EMBC: Prakiraan pendapatan perusahaan|TNDM (Tandem Diabetes) - Volume dodolan mangsa ngarep perusahaan|Axogen Surgical - Pendapatan mangsa ngarep perusahaan|SIBN (SI-BONE, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan orthofix.com OFIX|Prakiraan pendapatan perusahaan Bioventus (BVS)|orthopediatrics.com (KIDS) - Prakiraan dodolan perusahaan|Treace Medical - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Strata Medical SRTA|Carlsmed Inc - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan rxsight.com RXST|clearpointneuro.com (CLPT) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan STXS (Stereotaxis Inc)|Prakiraan pendapatan perusahaan NeuroStar|Volume dodolan mangsa ngarep perusahaan Sight Sciences Inc (SGHT)|Prakiraan volume dodolan OBIO|ANIK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan InspireMD NSPR|ZJYL: Prakiraan pendapatan perusahaan|VANI: Volume dodolan mangsa ngarep perusahaan|Xtant Medical Holdings - Prakiraan volume pendapatan perusahaan|NMTC: Prakiraan volume dodolan|MODD - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Myomo|COCH: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VVOS|Prakiraan volume dodolan enVVeno Corp (NVNO)|Prakiraan volume dodolan SINT (Sintx Technologies, Inc.)|TNON: Prakiraan pendapatan perusahaan|Lifeward - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Autonomix Medical, Inc. AMIX|INVO Bioscience, Inc. (IVF) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Bone Biologics Inc|AXNX (Axonics, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan biolase.com BIOL|Prakiraan volume dodolan DYNT|paragon28.com - Prakiraan pendapatan perusahaan|INVO Bioscience - Volume dodolan mangsa ngarep perusahaan
